Erste Studien geben Hinweise, dass die Abnehmspritze mit einem geringeren Risiko für Demenz einhergeht und Suchtreaktionen ...

Medikamente wie Ozempic oder Wegovy gelten als Durchbruch bei Diabetes und Adipositas. Nun deutet eine neue Studie darauf hin ...

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now ...

WHO guidelines conditionally endorse long-term GLP-1 therapy for obesity, emphasizing lifestyle modifications and addressing affordability and access challenges. GLP-1 therapies are included in the ...

GLP-1 medications treat type 2 diabetes and obesity by mimicking a hormone that helps manage blood sugar. A balanced diet can improve how well these medications work. The best foods to eat while on ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. There have been many headlines in the last week about $50 weight-loss drugs for Medicare ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...